Around one in three people say control of their respiratory condition worsened after their inhaler was switched, according to new findings ...
Incruse Ellipta (umeclidinium) is a prescription drug used for treating chronic obstructive pulmonary disease (COPD). Incruse Ellipta can cause side effects that range from mild to serious. Examples ...
Switching from a metered-dose to a dry-powder inhaler after a formulary change increased emergency department visits and hospitalizations in people with COPD or asthma. The absolute changes in risk ...
Reduced glutathione or simply glutathione (γ-glutamylcysteinylglycine; GSH) is found in the cytosol of most cells of the body. GSH in the epithelial lining fluid (ELF) of the lower respiratory tract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results